期刊文献+

小RNA干扰PDK1抑制乳腺肿瘤细胞侵袭 被引量:3

Small Interfering RNA targeting PDK1 Inhibits Breast Cancer Cell Line Invasion and Metastasis
下载PDF
导出
摘要 目的:在肿瘤侵袭转移的细胞和生物学机制中,包含有多种基因和信号传导通路的改变。PDK1是PI3K分子通路上的一个重要分子,为了研究PDK1对乳腺肿瘤细胞侵袭能力的影响,我们以乳腺癌MDA-MB-231细胞为研究模型,用小RNA干扰法特异下调PDK1的表达,研究其侵袭能力的变化,为乳腺癌临床治疗探索新的分子靶点。方法:通过构建PDK1特异的小RNA干扰质粒,利用脂质体介导的方法转染乳腺癌细胞MDA-MB-231,无限稀释法筛选单克隆细胞系,并通过Western Blot的方法检测各组细胞中PDK1蛋白的表达水平,细胞计数的方法观察各组细胞之间的增殖情况,并利用Matrigel Transwell的实验方法研究细胞在体外的侵袭能力差别。结果:MDA-MB-231细胞经小RNA干扰后PDK1蛋白表达水平明显下降,与对照组相比,细胞的生长增殖能力没有显著差异(P>0.05),细胞的侵袭能力显著下降,并且差异有统计学意义(P<0.05)。结论:MDA-MB-231是一种侵袭能力高的乳腺癌细胞系,本研究利用小RNA干扰技术,特异性下调了乳腺癌MDA-MB-231细胞中的PDK1蛋白表达,结果表明,乳腺癌细胞的生长能力与对照组的细胞相比没有明显差别,但是,PDK1蛋白表达水平下降后乳腺癌细胞的侵袭能力明显下降,提示我们PDK1可能与乳腺癌MDA-MB-231细胞的侵袭能力肾密相关。鉴于PDK1处于PDK1-Akt-PKC信号通路的上游,以PDK1为靶标的分子干预可能对乳腺癌细胞的侵袭转移起到有效的作用。 Objective: Understanding of the cellular and molecular basis of tumor metastasis inevitably brings up the challenging fact that metastasis is a complex multistep biological process most likely controlled by distinct genes and signaling pathways at each step. PDK1 is a key molecule that couples PI3K to cell proliferation and survival signals in response to growth factor receptor activation. PDK1 is oncogenic when expressed in mammary epithelial cells. In order to study the role of PDK1 in breast cancer cell invasion, we decreased PDK1 protein expression in MDA-MB-231 cells using small interfering RNA. Methods: We built a siRNA plasmid with the ability to specifically reduce PDK1 protein expression. Then we transfected the MDA-MB-231 breast cancer cells with the new plasmid in a lipid-mediated manner. We obtained the clone and assessed the PDK1 protein expression by Western blot. We assayed proliferation by cell counting and invasion using Transwell matrigel invasion chambers. Results: PDK1 protein expression was downregulated by siRNA expressed by the vector. Compared with the control group, cells transfected with the sJRNA vector had significantly decreased potency, with a statistical significance between the two groups (P〈0.05). Conclusion: MDA-MB-231 is a highly invasive breast cancer cell line. PDK1, an upstream signal transducer in the PI3K-Akt-PKC pathway, may play an important role in MDA-MB-231 invasion and may serve as an ideal target for molecular intervention against breast cancer invasion and metastasis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第12期697-700,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30772528)~~
关键词 PDK1 乳腺癌 侵袭 PDK1 Breast cancer Invasion
  • 相关文献

参考文献16

  • 1王洋,田琼,张绍章.淋巴管、VEGF-C与肿瘤转移[J].中国肿瘤临床,2004,31(14):833-835. 被引量:7
  • 2Dygas A, BaranskaJ. Lipids and signal transduction in the nucleus [J]. Acta Biochim Pol, 2001, 48(2): 541-549.
  • 3Mora A, Komander D, van Aalten DM, et al. PDK1, the master regulator of AGC kinase signal transduction[J]. Semin Cell Dev Biol, 2004, 15(2): 161-170.
  • 4Komander D, Fairservice A, Deak M,et al. Structural insights into the regulation of PDK1 by phosphoinosiddes and inositol phosphates[J]. EMBOJ, 2004, 23(20):3918-3928.
  • 5Biondi RM. Phosphoinositide--dependent protein kinase 1, a sensor of protein conformation[J]. Trends Biochem Sci, 2004, 29(3): 136-142.
  • 6Wick MJ, Ramos FJ, Chen H, et al. Mouse 3-phosphoinositide-dependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loop[J]. J Biol Chem, 2003, 278(44): 42913-42919.
  • 7Liang K, Lu Y, Li X, et al. Differential roles of phosphoinositide--dependent protein kinase--1 and aktl expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabine[J], Mol Pharmacol, 2006, 70(3): 1045-1052.
  • 8Lin HJ, Hsieh FC, Song H, et al. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer[J]. Br J Cancer, 2005, 93(12): 1372--1381.
  • 9Zeng X, Xu H, Glazer RI. Transformation of mammary epithelial ceils by 3--phosphoinositide---dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha[J]. Cancer Res, 2002, 62(12): 3538-3543.
  • 10Xie Z, Yuan H, Yin Y, et al. 3-phosphoinositide-dependent protein kinase--1 ('PDK1) promotes invasion and activation of matrix metaUoproteinases[J]. BMC Cancer, 2006, 6: 77.

二级参考文献61

  • 1石梅,魏丽春.胶质瘤的靶向放射治疗及分子靶向治疗[J].中华神经外科疾病研究杂志,2006,5(4):289-291. 被引量:7
  • 2[1]Lawrence B, Anthony G, Stuart S, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of breast[J]. Clin cancer Res, 1999, 5(5):1041 ~ 1056
  • 3[2]Ase Bratland, Karianne R, Gunhild M, et al. Expression of a novel factor, coml., is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells[J]. Cancer Res, 2000, 60(19):5578~5583
  • 4[3]Silvia F, Juan F, Dennis S, et al. Expression of metastases associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle [J]. Clin Cancer Res, 2000,6(12):4653~4657
  • 5[4]Hiro-omi K, Kinoya Y, Yasushi K, et al. Prognostic value matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer[J]. Cancer, 1998, 82(7):1359 ~ 1366
  • 6[5]Liu S, Sarah Netzel-Arnett, Henning Birkedal-Hansen, et al. Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin[J]. Cancer Res, 2000, 60(21):6061~6067
  • 7[6]Yang GY, Zhang ZH, Liao J, et al. Immunohistochemical studies on waf1/P21WAF1,p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in Northern China[J]. IntJ Cancer, 1997, 72(5):67
  • 8[7]Leivonen M, Nording S, Lundin J, et al. P27Kipl expression correlates with short-term, but not with long-term prognosis in breast cancer[J]. Breast Cancer Res Treat., 2001, 67(1):15~22
  • 9[8]Akano Y, Kato Y, Paul J, et al. cyclinD1 overexpression and lack of P27Kipl correlate positively and cyclin E with poor prognosis in gastric cancer [J]. American Journal Pathology, 2000, 156(2):585 ~ 594
  • 10[9]Weinstein IB. Disorders in cell circuitry during multistage carcinomagenesis: the role of homeostasis [J]. Carcinogenesis, 2000, 21(5) :857 ~ 864

共引文献16

同被引文献38

  • 1侯意枫,袁胜涛,李鹤成,吴炅,陆劲松,陆丽娟,刘刚,沈镇宙,丁健,邵志敏.雌激素受体β亚型对人乳腺癌细胞株生物学特性的影响[J].中华肿瘤杂志,2005,27(7):389-392. 被引量:10
  • 2王平章,王欣,罗楹,吴俊.3-磷酸肌醇依赖性蛋白激酶-1激活AGC家族激酶的机制研究进展[J].中国生物化学与分子生物学报,2005,21(6):723-731. 被引量:9
  • 3高德宗,孙靖中,高华,余之刚,唐鲁兵.γ-干扰素增强他莫昔芬抗乳腺癌作用的体外研究[J].中国肿瘤生物治疗杂志,2006,13(1):45-49. 被引量:4
  • 4Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure [J]. J Am Soc Nephrol, 2006, 17(1): 17-25.
  • 5WelborenWJ, Sweep FC, Span PN, et al. Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? [J]. Endocr Relat Cancer, 2009, 16(4): 1073-1089.
  • 6Paech K, Webb P, Kuiper GG, etal. Differential ligand acti- vation of estrogen receptors ERalpha and ERbeta at AP1 sites [J]. Science, 1997, 277(5331): 1508-1510.
  • 7Hayashi SI, Eguchi H, Tanimoto K, et al. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application [J]. Endocr Relat Cancer, 2003, 10(2): 193-202.
  • 8Meacham WD, Antoon JW, Burow ME, et al. Sphingolipids as determinants of apoptosis and ehemoresistanee in the MCF-7 cell model system [J]. Exp Biol Med (Maywood), 2009, 234 (11): 1253-1263.
  • 9Speirs V. Oestrogen receptor in breast cancer: good, bad or still too early to tell [J]. J Pathol, 2002, 197(2): 143-147.
  • 10Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen signa- ling via estrogen receptor beta [J]. J Biol Chem, 2010, 285 (51) : 39575-39579.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部